- Portable
- Standalone
Widefield Imaging Devices Market Size was valued at USD 548.5 million in 2022 and is poised to grow at a significant CAGR of 8.4% over 2023-2029. Upgrades in telemedicine and portable camera technology have made these devices easier to use and more accessible, and other new breakthroughs are expected to grow the market for wide-field imaging devices. Widefield imaging techniques may have a substantial impact on patient care in the future, but more study is needed to establish the clinical importance of peripheral data and to solve widefield imaging's optical flaws. Nonetheless, this fascinating technology has attracted people's interest. As the area of retinal imaging advances, understanding of ocular disease processes improves. Newer technologies, which address the need of ophthalmologists towards achieving the proper diagnosis and appropriate management of disease entities, have helped improve patient care and management ultimately in our current ophthalmic practice.
Widefield Imaging Devices Market Key Developments:
- In March 2022, epipole, an emerging provider of world-class handheld fundus cameras, launched the epiCam fundus camera to the US Eye Care market, at the Vision Expo East in New York City.
- In 2019, Leica Camera AG and pad technologies ag, the leading fabless IC supplier of high-performance Time-of-Flight (ToF) depth sensing solutions, entered into a strategic alliance to jointly develop and market 3D sensing camera solutions for mobile devices.
- In July 2019, Carl Zeiss received FDA 510(k) for the Clarus 700 ultra-wide field imaging device. This is a high-resolution ultra-wide field imaging system that includes fluorescein angiography and a variety of fundus imaging modalities.
- In September 2017, Carl Zeiss Meditec launched Zeiss Clarus 500, an ultra-wide field imaging fundus imaging system in the U.S.
Widefield Imaging Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.4%
Largest Market
North America
Fastest Growing Market
North America
Widefield Imaging Devices Market Dynamics
Diabetic retinopathy is becoming more common, as diabetes is the major cause of new occurrences of blindness in people. As the number of people living with diabetes rises, so does the number of people who suffer from vision impairment. According to a recent study done by the CDC, diabetic retinopathy affects over one-third of persons over the age of 40 who have diabetes, and more than one-third of African Americans and Mexican Americans. Over the forecast period, the worldwide widefield imaging systems market is expected to rise due to the rising prevalence of diabetic retinopathy. However, the company's growth may be hampered by a stringent regulatory framework and hefty gadget costs.
North-America Got Significant Share
Widefield Imaging Devices Market Regional Analysis
The widefield imaging devices market in North America is likely to hold a highest revenue share of 40% in 2021 and in the following years, it is predicted to increase at a rapid rate. The vast number of diabetic retinopathy cases, acceptance of newest innovations in ophthalmic practice, and developments such as fluorescence imaging have all contributed to the region's rise. Furthermore, compatible innovations like as AI and 3D printing are expected to drive market expansion in this region. Further, Asia Pacific is the fastest growing region with a CAGR of 9.2%. The market's expansion is likely to be aided by the region's huge population, increasing access to healthcare, and rising disposable income.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Widefield Imaging Devices Market Segmentation
By Modality
By Indication
- Uveitis
- Retinopathy of Prematurity
- Retinal Vein Occlusion
- Pediatric Retinal Diseases
- Ocular Oncology
- Glaucoma
- Diabetic Retinopathy
- Chorioretinal Diseases
- Others
By Application
- Glaucoma
- Diabetic retinopathy
- Age- Related Macular Degeneration
- Central Serous Retinopathy
- Vitreous Traction
- Pediatric
- Point of Care
- Others
By End User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
Frequently Asked Questions
The Widefield Imaging Devices Market is projected to expand at a CAGR of 8.4% during the forecast period.
Clarity Medical Systems, Inc., Epipole Ltd., Forus Health Pvt Ltd, Heidelberg Engineering Inc.
Asia-Pacific is the fastest-growing region for Widefield Imaging Devices Market
| 1.Executive Summary |
| 2.Global Widefield Imaging Devices Market Introduction |
| 2.1.Global Widefield Imaging Devices Market - Taxonomy |
| 2.2.Global Widefield Imaging Devices Market - Definitions |
| 2.2.1. By Modality |
| 2.2.2. By Indication |
| 2.2.3. By Application |
| 2.2.4. By End-User |
| 2.2.5.Region |
| 3.Global Widefield Imaging Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Widefield Imaging Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Widefield Imaging Devices Market By Modality, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Portable |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Standalone |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Widefield Imaging Devices Market By Indication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Uveitis |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Retinopathy of Prematurity |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Retinal Vein Occlusion |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Pediatric Retinal Diseases |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Ocular Oncology |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Glaucoma |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Diabetic Retinopathy |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Chorioretinal Diseases |
| 6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 6.9. Others |
| 6.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.9.3. Market Opportunity Analysis |
| 7.Global Widefield Imaging Devices Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Glaucoma |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diabetic retinopathy |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Age- Related Macular Degeneration |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Central Serous Retinopathy |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Vitreous Traction |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Pediatric |
| 7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Point of Care |
| 7.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 7.8. Others |
| 7.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.8.3. Market Opportunity Analysis |
| 8.Global Widefield Imaging Devices Market By End-User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Ambulatory Surgical Centers |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospitals |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Specialty Clinics |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Widefield Imaging Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Widefield Imaging Devices Market 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Modality Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Portable |
| 10.1.2.Standalone |
| 10.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Uveitis |
| 10.2.2.Retinopathy of Prematurity |
| 10.2.3.Retinal Vein Occlusion |
| 10.2.4.Pediatric Retinal Diseases |
| 10.2.5.Ocular Oncology |
| 10.2.6.Glaucoma |
| 10.2.7.Diabetic Retinopathy |
| 10.2.8.Chorioretinal Diseases |
| 10.2.9.Others |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Glaucoma |
| 10.3.2.Diabetic retinopathy |
| 10.3.3.Age- Related Macular Degeneration |
| 10.3.4.Central Serous Retinopathy |
| 10.3.5.Vitreous Traction |
| 10.3.6.Pediatric |
| 10.3.7.Point of Care |
| 10.3.8.Others |
| 10.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Ambulatory Surgical Centers |
| 10.4.2.Hospitals |
| 10.4.3.Specialty Clinics |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Widefield Imaging Devices Market 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Portable |
| 11.1.2.Standalone |
| 11.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Uveitis |
| 11.2.2.Retinopathy of Prematurity |
| 11.2.3.Retinal Vein Occlusion |
| 11.2.4.Pediatric Retinal Diseases |
| 11.2.5.Ocular Oncology |
| 11.2.6.Glaucoma |
| 11.2.7.Diabetic Retinopathy |
| 11.2.8.Chorioretinal Diseases |
| 11.2.9.Others |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Glaucoma |
| 11.3.2.Diabetic retinopathy |
| 11.3.3.Age- Related Macular Degeneration |
| 11.3.4.Central Serous Retinopathy |
| 11.3.5.Vitreous Traction |
| 11.3.6.Pediatric |
| 11.3.7.Point of Care |
| 11.3.8.Others |
| 11.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Ambulatory Surgical Centers |
| 11.4.2.Hospitals |
| 11.4.3.Specialty Clinics |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Widefield Imaging Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Portable |
| 12.1.2.Standalone |
| 12.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Uveitis |
| 12.2.2.Retinopathy of Prematurity |
| 12.2.3.Retinal Vein Occlusion |
| 12.2.4.Pediatric Retinal Diseases |
| 12.2.5.Ocular Oncology |
| 12.2.6.Glaucoma |
| 12.2.7.Diabetic Retinopathy |
| 12.2.8.Chorioretinal Diseases |
| 12.2.9.Others |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Glaucoma |
| 12.3.2.Diabetic retinopathy |
| 12.3.3.Age- Related Macular Degeneration |
| 12.3.4.Central Serous Retinopathy |
| 12.3.5.Vitreous Traction |
| 12.3.6.Pediatric |
| 12.3.7.Point of Care |
| 12.3.8.Others |
| 12.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Ambulatory Surgical Centers |
| 12.4.2.Hospitals |
| 12.4.3.Specialty Clinics |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Widefield Imaging Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Portable |
| 13.1.2.Standalone |
| 13.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Uveitis |
| 13.2.2.Retinopathy of Prematurity |
| 13.2.3.Retinal Vein Occlusion |
| 13.2.4.Pediatric Retinal Diseases |
| 13.2.5.Ocular Oncology |
| 13.2.6.Glaucoma |
| 13.2.7.Diabetic Retinopathy |
| 13.2.8.Chorioretinal Diseases |
| 13.2.9.Others |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Glaucoma |
| 13.3.2.Diabetic retinopathy |
| 13.3.3.Age- Related Macular Degeneration |
| 13.3.4.Central Serous Retinopathy |
| 13.3.5.Vitreous Traction |
| 13.3.6.Pediatric |
| 13.3.7.Point of Care |
| 13.3.8.Others |
| 13.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Ambulatory Surgical Centers |
| 13.4.2.Hospitals |
| 13.4.3.Specialty Clinics |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Widefield Imaging Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Portable |
| 14.1.2.Standalone |
| 14.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Uveitis |
| 14.2.2.Retinopathy of Prematurity |
| 14.2.3.Retinal Vein Occlusion |
| 14.2.4.Pediatric Retinal Diseases |
| 14.2.5.Ocular Oncology |
| 14.2.6.Glaucoma |
| 14.2.7.Diabetic Retinopathy |
| 14.2.8.Chorioretinal Diseases |
| 14.2.9.Others |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Glaucoma |
| 14.3.2.Diabetic retinopathy |
| 14.3.3.Age- Related Macular Degeneration |
| 14.3.4.Central Serous Retinopathy |
| 14.3.5.Vitreous Traction |
| 14.3.6.Pediatric |
| 14.3.7.Point of Care |
| 14.3.8.Others |
| 14.4. End-User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Ambulatory Surgical Centers |
| 14.4.2.Hospitals |
| 14.4.3.Specialty Clinics |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Carl Zeiss Meditec AG |
| 15.2.2.CENTERVUE S.P.A. |
| 15.2.3.Clarity Medical Systems, Inc. |
| 15.2.4.Epipole Ltd. |
| 15.2.5.Forus Health Pvt Ltd |
| 15.2.6.Heidelberg Engineering Inc. |
| 15.2.7.Docs Eye Care |
| 15.2.8.Optos |
| 15.2.9.Phoenix Technology Group, LLC |
| 15.2.10.Visunex Medical Systems, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Carl Zeiss Meditec AG
- CENTERVUE S.P.A.
- Clarity Medical Systems, Inc.
- Epipole Ltd.
- Forus Health Pvt Ltd
- Heidelberg Engineering Inc.
- Medibell Medical Vision Technologies Ltd
- Docs Eye Care
- Optos
- Phoenix Technology Group, LLC
- Visunex Medical Systems, Inc.